ADRA1D Antikörper (N-Term)
Kurzübersicht für ADRA1D Antikörper (N-Term) (ABIN5539092)
Target
Alle ADRA1D Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This ADRA1D antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 1-30amino acids from the N-terminal region of human ADRA1D.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
-
For IHC-P starting dilution is: 1:25
For FACS starting dilution is: 1:25
For WB starting dilution is: 1:1000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))
-
Andere Bezeichnung
- ADRA1D
-
Hintergrund
- This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium.
-
Molekulargewicht
- 60 kDa
-
Gen-ID
- 146
-
UniProt
- P25100
Target
-